Abstract
SAR studies on a series of thiophene amide derivatives provided CB 2 receptor agonists. The activity of the compounds was characterized by radioligand binding determination, multiple functional assays, ADME, and pharmacokinetic studies. A representative compound with selectivity for CB 2 over CB 1 effectively produced analgesia in behavioral models of neuropathic, inflammatory, and postsurgical pain. Control experiments using a CB 2 antagonist demonstrated the efficacy in the pain models resulted from CB 2 agonism.
Original language | English (US) |
---|---|
Pages (from-to) | 2604-2608 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 22 |
Issue number | 7 |
DOIs | |
State | Published - Apr 1 2012 |
Keywords
- CB2 agonists
- Pain management
ASJC Scopus subject areas
- Drug Discovery
- Molecular Medicine
- Molecular Biology
- Biochemistry
- Clinical Biochemistry
- Pharmaceutical Science
- Organic Chemistry